Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Report: Pharma Research Budgets Jump 73% From Phase II to III

By Pharmaceutical Processing | August 19, 2004

DURHAM, NC (August 17, 2004) – Recent studies find that pharmaceutical companies increase market research investments by 73% between Phase II and Phase III clinical trials, according to Cutting Edge Information, a pharmaceutical consulting firm.

Pharmaceutical companies spend an average $679,000 in Phase II on marketresearch and increase spending to $1.18 million in Phase III, the firm reported. However, Market research spending easily can surpass $2 million in Phase III for drugs with significant blockbuster potential.

Cutting Edge also found that companies that increase market research investments during the early stages of product development establish more effective product-positioning strategies well before the product launch.

To download a free summary of the 141-page report, “Pre-Launch Pharmaceutical Market Research,” visit http://www.PharmaMarketResearch.com .The report showcases metrics and market research practices from several top companies. Profiled companies include Aventis, Eli Lilly, Pfizer, AstraZeneca, and Wyeth.

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE